Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

ILLUMINATING ROUTES TO 3D ORGANOBORON MOLECULES

Project description

Pioneering medicinal chemistry platform targeting 3D organoboron compounds

Drug development relies heavily on exploration of chemical space to discover the next functional molecules. Thus, it is limited by the capabilities of the platforms used to do this. The ERC-funded LUMIBOR project aims to create a pioneering platform targeting organoboron compounds, which are extensively used in medicinal chemistry. LUMIBOR will use boron hybridisation to unlock new excited-state reactivity paradigms leading to the discovery of innovative methods to access achiral and chiral 3D organoboron scaffolds. To do so, the project will develop new light-enabled activation methods and approaches to regulate activity, and all methods will be recorded in holistic guidelines enabling significant expansion of synthesis possibilities.

Objective

With a steadily growing, aging population, there is significant strain on the pharmaceutical sector to produce state of the art therapeutics for societal needs whilst respecting the finite resources provided by the environment. Prominent advances in drug design are reliant on chemical synthesis platforms allowing the efficient exploration of chemical space to discover next generation functional molecules. As a result, innovation is currently limited by the practical implementation of enabling methods, which often becomes the rate limiting factor in cutting-edge research: this is more pronounced when translating academic research to industrial settings. The current renaissance of organic photochemistry and light-driven processes in a broader sense provide an opportunity to reconcile the growing demand for new functional molecules with consideration of sustainability and atom economy. Inspired by the importance of organoboron motifs in medicinal chemistry, this EU action “LUMIBOR” will harness the untapped potential of boron hybridization and boron ligand design to unlock new excited state reactivity paradigms and thereby facilitate the discovery of new methods to access achiral and chiral 3D organoboron scaffolds. LUMIBOR will create a structural platform to utilize boron hybridization in the development of next generation light-enabled ACTIVATION methods. Understanding the correlation between hybridization and parameters such as excited state energy and adjacent bond dissociation energy will allow access to synthetically versatile, high-energy intermediates such as α-boryl radicals and the triplet excited state. Strategic control over boron hybridization will also be utilized to regulate REACTIVITY, by influencing radical philicty, spin density, and excited state lifetimes among other parameters. Collectively, LUMIBOR will create expansive guidelines to expand the synthesis arsenal by developing novel platforms to construct desirable 3D organoboron molecules.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-STG

See all projects funded under this call

Host institution

FREIE UNIVERSITAET BERLIN
Net EU contribution
€ 1 187 803,21
Address
KAISERSWERTHER STRASSE 16-18
14195 Berlin
Germany
Region
Berlin Berlin Berlin
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 187 803,23

Beneficiaries (2)